2021 Investor Day

Global presence with ability to serve multiple market models Long-standing history serving customers Brightree enabled further penetration of markets Best-in-class therapy increases adherence and drives preference to ResMed Mainly in North European countries; government tenders for supply of sleep therapy Developed strong relationships during pandemic, driven by ResMed's unique ability to quickly fulfill large short-term orders 1HME: Home Medical Equipment; DME: Durable Medical Equipment Focused on healthcare in Germany HME /DME 1 Home care provider Business calling for referrals and billing insurance Government sales ResMed Retail locations in Australia Direct-to-Consumer Subscription clubs in non-reimbursed markets Continuing to penetrate different markets, while expanding the channels that we serve O2021 ResMed | 2021 Investor Day – Sept 8, 2021 - 74

View entire presentation